These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6772638)

  • 1. ADP-ribosylation of histone H1. Identification of glutamic acid residues 2, 14, and the COOH-terminal lysine residue as modification sites.
    Ogata N; Ueda K; Kagamiyama H; Hayaishi O
    J Biol Chem; 1980 Aug; 255(16):7616-20. PubMed ID: 6772638
    [No Abstract]   [Full Text] [Related]  

  • 2. A third-generation method reveals cell lineage ancestry.
    Feinberg AP
    Nat Methods; 2013 Feb; 10(2):117-8. PubMed ID: 23361091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preserving ester-linked modifications reveals glutamate and aspartate mono-ADP-ribosylation by PARP1 and its reversal by PARG.
    Longarini EJ; Matić I
    Nat Commun; 2024 May; 15(1):4239. PubMed ID: 38762517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dynamic process of covalent and non-covalent PARylation in the maintenance of genome integrity: a focus on PARP inhibitors.
    Beneyton A; Nonfoux L; Gagné JP; Rodrigue A; Kothari C; Atalay N; Hendzel MJ; Poirier GG; Masson JY
    NAR Cancer; 2023 Sep; 5(3):zcad043. PubMed ID: 37609662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoenzymatic and Synthetic Approaches To Investigate Aspartate- and Glutamate-ADP-Ribosylation.
    Tashiro K; Wijngaarden S; Mohapatra J; Rack JGM; Ahel I; Filippov DV; Liszczak G
    J Am Chem Soc; 2023 Jun; 145(25):14000-14009. PubMed ID: 37315125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PARPs and ADP-ribosylation: Deciphering the complexity with molecular tools.
    Dasovich M; Leung AKL
    Mol Cell; 2023 May; 83(10):1552-1572. PubMed ID: 37119811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Insights on PARP-1 Activity in Cancer Therapy.
    Pinton G; Boumya S; Ciriolo MR; Ciccarone F
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus-Host Interplay Between Poly (ADP-Ribose) Polymerase 1 and Oncogenic Gammaherpesviruses.
    Chung WC; Song MJ
    Front Microbiol; 2021; 12():811671. PubMed ID: 35095818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal and Site-Specific ADP-Ribosylation Dynamics upon Different Genotoxic Stresses.
    Buch-Larsen SC; Rebak AKLFS; Hendriks IA; Nielsen ML
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulatory landscape of the human HPF1- and ARH3-dependent ADP-ribosylome.
    Hendriks IA; Buch-Larsen SC; Prokhorova E; Elsborg JD; Rebak AKLFS; Zhu K; Ahel D; Lukas C; Ahel I; Nielsen ML
    Nat Commun; 2021 Oct; 12(1):5893. PubMed ID: 34625544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of mono-ADP-ribosylation histone modification (Review).
    Zha JJ; Tang Y; Wang YL
    Exp Ther Med; 2021 Jun; 21(6):577. PubMed ID: 33850549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Tools for the Study of ADP-Ribosylation: A Unified and Versatile Method to Synthesise Native Mono-ADP-Ribosylated Peptides.
    Voorneveld J; Rack JGM; van Gijlswijk L; Meeuwenoord NJ; Liu Q; Overkleeft HS; van der Marel GA; Ahel I; Filippov DV
    Chemistry; 2021 Jul; 27(41):10621-10627. PubMed ID: 33769608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific analysis of the Asp- and Glu-ADP-ribosylated proteome by quantitative mass spectrometry.
    Li P; Zhen Y; Yu Y
    Methods Enzymol; 2019; 626():301-321. PubMed ID: 31606080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly-ADP ribosylation in DNA damage response and cancer therapy.
    Hou WH; Chen SH; Yu X
    Mutat Res Rev Mutat Res; 2019; 780():82-91. PubMed ID: 31395352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human alcohol dehydrogenase 1 is an acceptor protein for polyADP-ribosylation.
    Yamashita S; Tanaka M; Nodono H; Hamada A; Hamada T; Hasegawa M; Nishi Y; Moss J; Miwa M
    Biochem Pharmacol; 2019 Sep; 167():27-32. PubMed ID: 30936015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying Genomic Sites of ADP-Ribosylation Mediated by Specific Nuclear PARP Enzymes Using Click-ChIP.
    Rogge RA; Gibson BA; Kraus WL
    Methods Mol Biol; 2018; 1813():371-387. PubMed ID: 30097881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic Analysis of the Downstream Signaling Network of PARP1.
    Zhen Y; Yu Y
    Biochemistry; 2018 Jan; 57(4):429-440. PubMed ID: 29327913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nucleosomal surface is the main target of histone ADP-ribosylation in response to DNA damage.
    Karch KR; Langelier MF; Pascal JM; Garcia BA
    Mol Biosyst; 2017 Nov; 13(12):2660-2671. PubMed ID: 29058739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of poly ADP-ribosylation in the first wave of DNA damage response.
    Liu C; Vyas A; Kassab MA; Singh AK; Yu X
    Nucleic Acids Res; 2017 Aug; 45(14):8129-8141. PubMed ID: 28854736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-specific ADP-ribosylation of histone H2B in response to DNA double strand breaks.
    Rakhimova A; Ura S; Hsu DW; Wang HY; Pears CJ; Lakin ND
    Sci Rep; 2017 Mar; 7():43750. PubMed ID: 28252050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.